Human leukocyte antigen phenotype imposes complex constraints on the antigen‐specific cytotoxic T lymphocyte repertoire

The memory response to the immunodominant Epstein‐Barr virus (EBV) epitope FLRGRAYGL, which associates with HLA B8, is exceptionally restricted, being dominated by cytotoxic T lymphocytes (CTL) with a single, public T cell receptor (TCR). CTL clones that express this receptor fortuitously cross‐react with the alloantigen HLA B44. However, of the two major subtypes of this HLA, B*4402 and B*4403, that differ by a single amino acid, only the former is recognized by these mature CTL clones. Individuals heterozygous for HLA B8 and B*4402 use alternative TCR for the EBV determinant since the dominant TCR is potentially self‐reactive. We now demonstrate that this clonotype is also essentially absent from the repertoire of CTL directed against the viral epitope in seven from seven unrelated individuals heterozygous for HLA B8 and B*4403. Thus immune tolerance of these CTL recognizing HLA B*4402 is associated with expression of either B*4402 or B*4403. This suggests that tolerance in the human T cell compartment requires a lower threshold of recognition than for effector function, thus providing a buffer zone minimizing the risk of autoimmunity. These data also illustrate the potential for non‐restricting HLA molecules to bias dramatically the T cell repertoire used for specific immune responses. Such influences may be the basis of the “protective” effects of certain HLA alleles in susceptibility to autoimmune disorders.

[1]  W. O'Fallon,et al.  Mechanisms underlying the formation of the T cell receptor repertoire in rheumatoid arthritis. , 1995, Immunity.

[2]  H. Pircher,et al.  Lower receptor avidity required for thymic clonal deletion than for effector T-cell function , 1991, Nature.

[3]  G. Schönrich,et al.  T cell activation and thymic tolerance induction require different adhesion intensities of the CD8 co-receptor. , 1992, International immunology.

[4]  J. Bell,et al.  T‐Cell Receptor Usage of Major Histocompatibility Complex Class I Restricted Peptide‐Specific T‐Lymphocytes , 1995, Annals of the New York Academy of Sciences.

[5]  U. Utz,et al.  Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis , 1993, Nature.

[6]  G. J. V. Nossal,et al.  Negative selection of lymphocytes , 1994, Cell.

[7]  C. Janeway,et al.  Ligand thresholds at different stages of T cell development. , 1990, International immunology.

[8]  A. Lanzavecchia,et al.  Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy , 1996, The Journal of experimental medicine.

[9]  E. Timms,et al.  Tolerance of self induced in thymus organ culture , 1992, European journal of immunology.

[10]  C. Bordignon,et al.  Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. , 1994, Tissue antigens.

[11]  S. Hedrick,et al.  In vivo and in vitro clonal deletion of double-positive thymocytes , 1992, The Journal of experimental medicine.

[12]  L. Sherman,et al.  The molecular basis of allorecognition. , 1993, Annual review of immunology.

[13]  S. Tonegawa,et al.  Evidence for a differential avidity model of T cell selection in the thymus , 1994, Cell.

[14]  S. Burrows,et al.  Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants , 1988, Nature.

[15]  J. Burrows,et al.  An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease , 1994, The Journal of experimental medicine.

[16]  A. Fauci,et al.  New concepts in the immunopathogenesis of HIV infection. , 1995, Annual review of immunology.

[17]  D. Mark,et al.  Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. , 1984, Science.

[18]  M. Bevan,et al.  Positive selection of thymocytes. , 1995, Annual review of immunology.

[19]  R. Houghten General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Todd,et al.  A molecular basis for MHC class II--associated autoimmunity. , 1988, Science.

[21]  D J Moss,et al.  Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus , 1994, The Journal of experimental medicine.

[22]  M. Doyle,et al.  Biological activity of recombinant human interleukin-2 produced in Escherichia coli. , 1984, Science.

[23]  S. L. Silins,et al.  T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen , 1995, The Journal of experimental medicine.

[24]  W. Henle,et al.  Immunofluorescence in Cells Derived from Burkitt's Lymphoma , 1966, Journal of bacteriology.

[25]  G. Hitman,et al.  New HLA DNA polymorphisms associated with autoimmune diseases , 1986, Nature.

[26]  H. Grey,et al.  Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Begovich,et al.  Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis , 1993, Nature.